Elz S - Search Results

1

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.

Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J. Ligneau X, et al. Among authors: elz s. J Pharmacol Exp Ther. 1998 Nov;287(2):658-66. J Pharmacol Exp Ther. 1998. PMID: 9808693

2

Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.

Grassmann S, Sadek B, Ligneau X, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Stark H, Schunack W. Grassmann S, et al. Among authors: elz s. Eur J Pharm Sci. 2002 May;15(4):367-78. doi: 10.1016/s0928-0987(02)00024-6. Eur J Pharm Sci. 2002. PMID: 11988398

3

Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.

Sasse A, Ligneau X, Rouleau A, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Sasse A, et al. Among authors: elz s. J Med Chem. 2002 Aug 29;45(18):4000-10. doi: 10.1021/jm020910m. J Med Chem. 2002. PMID: 12190321

4

Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity.

Sasse A, Stark H, Reidemeister S, Hüls A, Elz S, Ligneau X, Ganellin CR, Schwartz JC, Schunack W. Sasse A, et al. Among authors: elz s. J Med Chem. 1999 Oct 7;42(20):4269-74. doi: 10.1021/jm991068w. J Med Chem. 1999. PMID: 10514298

5

(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors.

Sasse A, Stark H, Ligneau X, Elz S, Reidemeister S, Ganellin CR, Schwartz JC, Schunack W. Sasse A, et al. Among authors: elz s. Bioorg Med Chem. 2000 May;8(5):1139-49. doi: 10.1016/s0968-0896(00)00050-x. Bioorg Med Chem. 2000. PMID: 10882024

6

New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.

Sasse A, Sadek B, Ligneau X, Elz S, Pertz HH, Luger P, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Sasse A, et al. Among authors: elz s. J Med Chem. 2000 Aug 24;43(17):3335-43. doi: 10.1021/jm000971p. J Med Chem. 2000. PMID: 10966752

7

Benzophenone derivatives and related compounds as potent histamine H3-receptor antagonists and potential PET/SPECT ligands.

Sasse A, Ligneau X, Sadek B, Elz S, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Sasse A, et al. Among authors: elz s. Arch Pharm (Weinheim). 2001 Feb;334(2):45-52. doi: 10.1002/1521-4184(200102)334:2<45::aid-ardp45>3.0.co;2-2. Arch Pharm (Weinheim). 2001. PMID: 11268774

8

Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists.

Meier G, Apelt J, Reichert U, Grassmann S, Ligneau X, Elz S, Leurquin F, Ganellin CR, Schwartz JC, Schunack W, Stark H. Meier G, et al. Among authors: elz s. Eur J Pharm Sci. 2001 Jun;13(3):249-59. doi: 10.1016/s0928-0987(01)00106-3. Eur J Pharm Sci. 2001. PMID: 11384847

9

Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.

Kieć-Kononowicz K, Wiecek M, Sasse A, Ligneau X, Elz S, Ganellin CR, Schwartz JC, Stark H, Schunack W. Kieć-Kononowicz K, et al. Among authors: elz s. Pharmazie. 2000 May;55(5):349-55. Pharmazie. 2000. PMID: 11828613

10

Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.

Sadek B, Elz S, Pertz HH, Stark H, Schunack W. Sadek B, et al. Among authors: elz s. Inflamm Res. 2004 Aug;53 Suppl 2:S109-15. doi: 10.1007/s00011-004-0351-8. Epub 2004 Aug 10. Inflamm Res. 2004. PMID: 15338060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters